9AT: KYNAM CAPITAL MANAGEMENT, LP

other names

KYNAM CAPITAL MANAGEMENT, LP

Adviser Profile

As of Date	04/10/2026
Registration	SEC, Approved, 07/22/2022
Other registrations (1)	SEC, ERA - Withdrawn, 06/24/2022
Former registrations	KYNAM CAPITAL MANAGEMENT, LP
Contact Info	574 xxxxxxx

AUM^*	2,405,442,793 31%
of that, discretionary	2,405,442,793 31%
Private Fund GAV^*	2,405,442,793 11%
Avg Account Size	801,814,264 119%
SMA’s	No
Private Funds	3

Adviser Type

- Large advisory firm

Number of Employees 3

of those in investment advisory functions 2

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

SEC Fund Type	Count	GAV
Fund TypeHedge Fund	Count3	GAV$2,405,442,793

Adviser	Hedge Fund	Liquidity Fund	Private Equity Fund	Real Estate Fund	Securitized Asset Fund	Venture Capital Fund	Other Fund	Total Private Fund GAV	AUM	#Funds
Adviser CAPTION MANAGEMENT, LLC	Hedge Fund1.2b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV1.2b	AUM3.4b	#Funds2
Adviser QTRON INVESTMENTS LLC	Hedge Fund431.5k	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV431.5k	AUM1.2b	#Funds2
Adviser OPTI CAPITAL MANAGEMENT LP	Hedge Fund657.4m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV657.4m	AUM1.8b	#Funds3
Adviser IRON TRIANGLE PARTNERS LP	Hedge Fund264.7m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV264.7m	AUM1.1b	#Funds4
Adviser LIBRARY RESEARCH LIMITED	Hedge Fund1.2b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV1.2b	AUM1.2b	#Funds4
Adviser HILL CITY CAPITAL LP	Hedge Fund4.5b	Liquidity Fund-	Private Equity Fund362.7m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV4.9b	AUM4.9b	#Funds6
Adviser SOURCEROCK GROUP LLC	Hedge Fund1.5b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV1.5b	AUM3.1b	#Funds2
Adviser CURIAM CAPITAL LLC	Hedge Fund964.7m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV964.7m	AUM964.7m	#Funds4
Adviser GREENLAND CAPITAL MANAGEMENT LP	Hedge Fund2.2b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV2.2b	AUM2.2b	#Funds3
Adviser READYSTATE ASSET MANAGEMENT	Hedge Fund10.3b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV10.3b	AUM10.3b	#Funds9

Stock Ticker	Stock Name	$ Position	% Position	$ Change	# Change
Stck Ticker87164F105	Stock NameSYNDAX PHARMACEUTICALS INC	$ Position$188,070,402	% Position12.00%	$ Change11.00%	# Change0.00%
Stck Ticker15117B202	Stock NameCELLDEX THERAPEUTICS INC NEW	$ Position$185,262,785	% Position11.00%	$ Change15.00%	# Change-2.00%
Stck Ticker19240Q201	Stock NameCOGENT BIOSCIENCES INC	$ Position$155,396,870	% Position10.00%	$ Change-29.00%	# Change-35.00%
Stck Ticker92243G108	Stock NameVAXCYTE INC	$ Position$169,816,887	% Position10.00%	$ Change26.00%	# Change0.00%
Stck Ticker92337R101	Stock NameVERA THERAPEUTICS INC	$ Position$136,710,552	% Position8.00%	$ Change-21.00%	# Change-1.00%
Stck Ticker07373V105	Stock NameBEAM THERAPEUTICS INC	$ Position$87,746,469	% Position5.00%	$ Change30.00%	# Change51.00%
Stck Ticker23284F105	Stock NameCYTOMX THERAPEUTICS INC.	$ Position$70,561,537	% Position4.00%	$ Change85.00%	# Change67.00%
Stck Ticker230031106	Stock NameCULLINAN THERAPEUTICS INC	$ Position$44,251,816	% Position3.00%	$ Change37.00%	# Change0.00%
Stck Ticker89422G107	Stock NameTRAVERE THERAPEUTICS INC	$ Position$46,615,525	% Position3.00%	$ Change136.00%	# Change203.00%
Stck Ticker09058V103	Stock NameBIOCRYST PHARMACEUTICALS INC	$ Position$54,081,168	% Position3.00%	$ Change-26.00%	# Change-39.00%

Brochure Summary

Overview

Kynam Capital Management, LP (“Kynam” or the “Adviser”) was founded in October 2020 and is organized as a Delaware limited partnership. Yue “Derrick” Tang (the “Principal”) is the founder and principal owner of Kynam and is responsible for the management of the strategies employed by Kynam. Kynam Capital Management GP, LLC the (“General Partner”) is the General Partner of Kynam and is also principally owned by Mr. Tang. Kynam serves as the investment manager and provides discretionary advisory services to certain private funds organized in a master-feeder structure, as well as certain sub-advisory accounts for a third party registered investment adviser which are also structured as private funds. Collectively, the master-feeder and the sub-advised accounts will be referred to as “Clients.” Investors in the master-feeder structure shown below will be referred to as “Investors.” The following Clients are currently offered to qualified investors on a private placement basis: Kynam Global Healthcare Mater

Fund, LP, a Cayman Islands exempted partnership (the “Master Fund”), Kynam Global Healthcare Onshore Fund, LP, a Delaware limited partnership (the “Onshore Feeder”), Kynam Global Healthcare Offshore Fund, Ltd (the “Offshore Feeder”), (together the “Feeder Funds” and each a “Fund” and collectively the “Funds”). Kynam Fund GP, LLC the (“Fund GP”) is a related entity of the Adviser and serves as the general partner of the Onshore Feeder and Master Fund. Mr. Tang is the Managing Member and principal owner of the Fund GP. Kynam’s investment advisory services are provided pursuant to written investment advisory agreements between Kynam and the Clients to which Kynam agrees to advise in accordance with Client-mandated investment objectives. The Adviser has discretionary trading authority and does not tailor advisory services to the needs of specific Investors. As of December 31, 2023, Kynam has regulatory assets under management of $1,833,940,841, all of which is managed on a discretionary basis.

KYNAM CAPITAL MANAGEMENT, LP

Related Companies

Adviser Profile

Adviser Type

Client Types

Advisory Activities

Compensation Arrangments

Reported AUM

Private Funds

Employees

Private Funds Structure

Similar advisers

Top Holdings

Brochure Summary

Overview